Kelsey Millonig, DPM
Foot & Ankle Surgery · Des Moines, IANPI 1194176297
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $224,729 of the $330,114 with a category attached, or 68.1%. 19 manufacturers reported payments, led by Orthofix Medical, Inc. at 51.0% of the total. 2025 is the largest year on record at $120,474, more than ten times the $2,455 reported in 2020. Among foot & ankle surgery clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 553 payments — averaging $596.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$168K
- Arthrex$54K
- Stryker$40K
- Medical Device Business Services, Inc.$29K
- Vilex LLC$22K
- Medline Industries LP$9K
- plus $8K from 13 others
Across 1 payment — averaging $53,300 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthofix Medical, Inc.$53K
What the payments were for
- Consulting fees$224,72968%
- Speaking & faculty fees$45,25314%
- Travel & lodging$40,29312%
- Food & beverage$13,1694%
- Education$6,6602%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 231 | $168,195 |
| Arthrex | 84 | $54,344 |
| Stryker | 116 | $40,014 |
| Medical Device Business Services, Inc. | 21 | $28,658 |
| Vilex LLC | 26 | $21,607 |
| Medline Industries LP | 17 | $9,193 |
| Supreme Orthopedic Systems, LLC | 5 | $3,043 |
| Wardlow Enterprises | 15 | $2,635 |
| Johnson & Johnson | 17 | $799 |
| Prism Medical | 10 | $782 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $164 |
| Smith+Nephew | 1 | $135 |
| Arteriocyte Medical Systems, Inc. | 3 | $126 |
| AbbVie | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Restor3d, Inc. | 1 | $120 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Amgen | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$128,883
- MEDLINE INDUSTRIES, INC.$31,316
- HOFFMANN$30,548
- JUNIORTHO PLATING SYSTEM$24,390
- DYNEX$15,582
- TL-HEX TRUELOK HEXAPOD SYSTEM$12,987
- SALVATION$11,600
- PROstep$4,606
- REDEMPTION$4,091
- MEDLINE$3,000
- INFINITY$2,960
- mild Device Kit$2,800
- GAMMA$2,188
- AUGMENT INJECTABLE$1,988
- AXSOS$1,988
- VARIAX$1,988
- AXS INFINITY LS$1,657
- Artemis$1,603
- PENDING$1,500
- MEDLINE UNITE$1,500
How this compares
$330,114 in reported general payments places this provider in the 95th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 30 | $8,323 |
| Gabapentin | 52 | $363 |
| Oxycodone Hcl | 40 | $161 |
| Doxycycline Hyclate | 14 | $127 |
| Methylprednisolone | 17 | $102 |
| Meloxicam | 14 | $30 |
| Tramadol Hcl | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $799 | $8,32330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 112 foot & ankle surgery providers in Iowa.
Other foot & ankle surgery in Des Moines
- Michael LeeDes Moines$2.1M
- Sean GrambartDes Moines$590K
- Justin RaatzDes Moines$28K
- Mica MurdochDes Moines$25K
- Emily AnzmannDes Moines$15K
- Blake HaleDes Moines$14K
- Ashley McClainDes Moines$5K
- Monique RodriguezDes Moines$4K
- Erica ReedDes Moines$3K
- Phinit PhisitkulSioux City$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.